Effect of postinjury intravenous or intrathecal methylprednisolone on spinal cord excitatory amino-acid release, nitric oxide generation, PGE 2 synthesis, and myeloperoxidase content in a pig model of acute spinal cord injury

Spinal Cord

Volumn 44, Issue 10, 2006, Pages 594-604

  Bernards, C M ^a   Akers, T ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Aspartate; Glutamate; Methylprednisolone; Myeloperoxidase; Nitric oxide; PGE2

Indexed keywords

ASPARTIC ACID; CITRULLINE; EXCITATORY AMINO ACID; GLUTAMIC ACID; METHYLPREDNISOLONE; MYELOPEROXIDASE; NITRIC OXIDE; PROSTAGLANDIN E2;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG TISSUE LEVEL; FEMALE; IN VIVO STUDY; MALE; MEDIATOR; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPINAL CORD INJURY; SWINE; SWINE DISEASE;

ANALYSIS OF VARIANCE; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DINOPROSTONE; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION ROUTES; EXCITATORY AMINO ACIDS; FEMALE; MALE; MASS SPECTROMETRY; METHYLPREDNISOLONE; MICRODIALYSIS; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; PEROXIDASE; SPINAL CORD INJURIES; SWINE; TIME FACTORS;

EID: 33750156013     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sj.sc.3101891     Document Type: Article

References (50)

1. Yu Y, Matsuyama Y, Nakashima S, Yanase M, Kiuchi K, Ishiguro N. Effects of MPSS and a potent iNOS inhibitor on traumatic spinal cord injury. Neuroreport 2004; 15: 2103-2107.
2. Anderson DK et al. Lipid hydrolysis and peroxidation in injured spinal cord: partial protection with methylprednisolone or vitamin E and selenium. Central Nerv Syst Trauma 1985; 2: 257-267.
3. Saunders RD, Dugan LL, Demediuk P, Means ED, Horrocks LA, Anderson DK. Effects of methylprednisolone and the combination of alpha-tocopherol and selenium on arachidonic acid metabolism and lipid peroxidation in traumatized spinal cord tissue. J Neurochem 1987; 49: 24-31.
4. Liu D, McAdoo DJ. Methylprednisolone reduces excitatory amino acid release following experimental spinal cord injury. Brain Res 1993; 609: 293-297.
5. Farooque M, Hillered L, Holtz A, Olsson Y. Effects of methylprednisolone on extracellular lactic acidosis and amino acids after severe compression injury of rat spinal cord. J Neurochem 1996; 66: 1125-1130.
6. Liu D, Li L, Augustus L. Prostaglandin release by spinal cord injury mediates production of hydroxyl radical, malondialdehyde and cell death: a site of the neuroprotective action of methylprednisolone. J Neurochem 2001; 77: 1036-1047.
7. Gok A, Uk C, Yilmaz M, Bakir K, Erkutlu I, Alptekin M. Efficacy of methylprednisolone in acute experimental cauda equina injury. Acta Neurochir (Wien) 2002; 144: 817-821 (discussion 821).
8. Perez-Espejo MA, Haghighi SS, Adelstein EH, Madsen R. The effects of taxol, methylprednisolone, and 4-aminopyridine in compressive spinal cord injury: a qualitative experimental study. Surg Neurol 1996; 46: 350-357.
9. Behrmann DL, Bresnahan JC, Beattie MS. Modeling of acute spinal cord injury in the rat: neuroprotection and enhanced recovery with methylprednisolone, U-74006F and YM-14673. Exp Neurol 1994; 126: 61-75.
10. Farooque M, Olsson Y, Holtz A. Effect of the 21-aminosteroid U74006F and methylprednisolone on motor function recovery and oedema after spinal cord compression in rats. Acta Neurol Scand 1994; 89: 36-41.
11. Holtz A, Nystrom B, Gerdin B. Effect of methylprednisolone on motor function and spinal cord blood flow after spinal cord compression in rats. Acta Neurol Scand 1990; 82: 68-73.
12. Bracken MB et al. Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study. J Neurosurg 1985; 63: 704-713.
13. Bracken MB et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990; 322: 1405-1411.
14. Bracken MB et al. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study. J Neurosurg 1992; 76: 23-31.
15. Bracken MB et al. Administration of methylprednisolone for 24 or 48 h or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 1997; 277: 1597-1604.
16. Bracken MB et al. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. J Neurosurg 1998; 89: 699-706.
17. Bracken MB, Holford TR. Neurological and functional status 1 year after acute spinal cord injury: estimates of functional recovery in National Acute Spinal Cord Injury Study II from results modeled in National Acute Spinal Cord Injury Study III. J Neurosurg Spine 2002; 96: 259-266.
18. Pointillart V et al. Pharmacological therapy of spinal cord injury during the acute phase. Spinal Cord 2000; 38: 71-76.
19. Poynton AR, O'Farrell DA, Shannon F, Murray P, McManus F, Walsh MG. An evaluation of the factors affecting neurological recovery following spinal cord injury. Injury 1997; 28: 545-548.
20. Gerndt SJ et al. Consequences of high-dose steroid therapy for acute spinal cord injury. J Trauma 1997; 42: 279-284.
21. George ER, Scholten DJ, Buechler CM, Jordan-Tibbs J, Mattice C, Albrecht RM. Failure of methylprednisolone to improve the outcome of spinal cord injuries. Am Surg 1995; 61: 659-663 (discussion 663-664).
22. Carlson SL, Parrish ME, Springer JE, Doty K, Dossett L. Acute inflammatory response in spinal cord following impact injury. Exp Neurol 1998; 151: 77-88.
23. De Antonis KM, Brown PR, Cohen SA. High-performance liquid chromatographic analysis of synthetic peptides using derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate. Anal Biochem 1994; 223: 191-197.
24. Cohen SA, Michaud DP. Synthesis of a fluorescent derivatizing reagent, 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate, and its application for the analysis of hydrolysate amino acids via high-performance liquid chromatography. Anal Biochem 1993; 211: 279-287.
25. Hall ED, Yonkers PA, Taylor BM, Sun FF. Lack of effect of postinjury treatment with methylprednisolone or tirilazad mesylate on the increase in eicosanoid levels in the acutely injured cat spinal cord. J Neurotrauma 1995; 12: 245-256.
26. Liu D, Ling X, Wen J, Liu J. The role of reactive nitrogen species in secondary spinal cord injury: formation of nitric oxide, peroxynitrite, and nitrated protein. J Neurochem 2000; 75: 2144-2154.
27. Liu D, Sybert TE, Qian H, Liu J. Superoxide production after spinal injury detected by microperfusion of cytochrome c. Free Radic Biol Med 1998; 25: 298-304.
28. Luo J, Li N, Robinson JP, Shi R. The increase of reactive oxygen species and their inhibition in an isolated guinea pig spinal cord compression model. Spinal Cord 2002; 40: 656-665.
29. Xu W et al. Increased production of reactive oxygen species contributes to motor neuron death in a compression mouse model of spinal cord injury. Spinal Cord 2005; 43: 204-213.
30. 2+-calmodulin-regulated nitric oxide synthases. Cell Calcium 1992; 13: 427-434.
31. Fleming I, Bauersachs J, Busse R. Calcium-dependent and calcium-independent activation of the endothelial NO synthase. J Vasc Res 1997; 34: 165-174.
32. 2+-dependent NO-production from central nervous system cells in culture measured by NO-nitrite/ozone chemoluminescence. Brain Res 1997; 748: 1-11.
33. Stys PK. White matter injury mechanisms. Curr Mol Med 2004; 4: 113-130.
34. Liu D, Xu GY, Pan E, McAdoo DJ. Neurotoxicity of glutamate at the concentration released upon spinal cord injury. Neuroscience 1999; 93: 1383-1389.
35. Farooque M, Hillered L, Holtz A, Olsson Y. Effects of moderate hypothermia on extracellular lactic acid and amino acids after severe compression injury of rat spinal cord. J Neurotrauma 1997; 14: 63-69.
36. Farooque M, Hillered L, Holtz A, Olsson Y. Effect of 21-aminosteroid on extracellular energy-related metabolites and amino acids after compression injury of rat spinal cord. Exp Brain Res 1997; 113: 1-4.
37. Farooque M, Hillered L, Holtz A, Olsson Y. Changes of extracellular levels of amino acids after graded compression trauma to the spinal cord: an experimental study in the rat using microdialysis. J Neurotrauma 1996; 13: 537-548.
38. Xu GY, Hughes MG, Ye Z, Hulsebosch CE, McAdoo DJ. Concentrations of glutamate released following spinal cord injury kill oligodendrocytes in the spinal cord. Exp Neurol 2004; 187: 329-336.
39. Vera-Portocarrero LP et al. Rapid changes in expression of glutamate transporters after spinal cord injury. Brain Res 2002; 927: 104-110.
40. Mills CD et al. AIDA reduces glutamate release and attenuates mechanical allodynia after spinal cord injury. Neuroreport 2000; 11: 3067-3070.
41. Taoka Y, Okajima K. Role of leukocytes in spinal cord injury in rats. J Neurotrauma 2000; 17: 219-229.
42. Taoka Y et al. Role of neutrophils in spinal cord injury in the rat. Neuroscience 1997; 79: 1177-1182.
43. Naruo S et al. Prostaglandin E1 reduces compression trauma-induced spinal cord injury in rats mainly by inhibiting neutrophil activation. J Neurotrauma 2003; 20: 221-228.
44. Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-eukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1992; 89: 9991-9995.
45. Filep JG, Delalandre A, Payette Y, Foldes-Filep E. Glucocorticoid receptor regulates expression of L-selectin and CD11/CD18 on human neutrophils. Circulation 1997; 96: 295-301.
46. Molano Mdel R, Broton JG, Bean JA, Calancie B. Complications associated with the prophylactic use of methylprednisolone during surgical stabilization after spinal cord injury. J Neurosurg Spine 2002; 96: 267-272.
47. McCutcheon EP, Selassie AW, Gu JK, Pickelsimer EE. Acute traumatic spinal cord injury, 1993-2000A population-based assessment of methylprednisolone administration and hospitalization. J Trauma 2004; 56: 1076-1083.
48. Matsumoto T, Tamaki T, Kawakami M, Yoshida M, Ando M, Yamada H. Early complications of high-dose methylprednisolone sodium succinate treatment in the follow-up of acute cervical spinal cord injury. Spine 2001; 26: 426-430.
49. Galandiuk S, Raque G, Appel S, Polk Jr HC. The two-edged sword of large-dose steroids for spinal cord trauma. Ann Surg 1993; 218: 419-425; (discussion 425-427).
50. Koszdin KL, Shen DD, Bernards CM. Spinal cord bioavailability of methylprednisolone after intravenous and intrathecal administration: the role of P-glycoprotein. Anesthesiology 2000; 92: 156-163.